Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Workiva Inc (WK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Workiva Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B), while Workiva Inc trades at $72.22 (market cap $3.95B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 7.8× Workiva Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Workiva Inc pays none. Which is the better fit depends on your goals.
| GEHC | WK | |
|---|---|---|
Market Cap | $30.93B | $3.95B |
Volume | 5,033,451 | 1,200,755 |
Sector | Health | Technology |
52-Week High | $88.16 | $93.31 |
52-Week Low | $59.48 | $44.31 |
Enterprise Value | $39.39B | $3.93B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 20 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
WK trades at $72.50, down 0.74% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $86.00. The company has beaten earnings estimates for the last three quarters, with Q3 2026 results pending. Revenue grew to $966 million in 2026, turning a net loss in 2025 into a $47 million profit, reflecting improved operational efficiency and strong gross margins above 80%.
The outlook is positive given earnings beats, AI-driven product innovations, and inclusion in positive media coverage, but high valuation multiples like a P/E of 86.48 pose risks if growth slows. Investors should weigh the strong analyst buy consensus against execution risks in a competitive software market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Workiva Inc
Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →
